Depo-Provera: a critical analysis.
This article discusses the research which has led to the controversy of Depo-Provera, and delineates the risks discovered as a result of the studies. Questions are raised as to the advisability of the continued use of this drug.
D000014:Abnormalities, Drug-Induced / Q000209:etiology; D000818:Animals; D001942:Breast Feeding; D003271:Contraceptive Agents, Female / Q000009:adverse effects*; D004285:Dogs; D005260:Female; D000882:Haplorhini; D006801:Humans; D008525:Medroxyprogesterone / Q000009:adverse effects / Q000031:analogs & derivatives*; D017258:Medroxyprogesterone Acetate; D008895:Milk, Human / Q000187:drug effects*; D009369:Neoplasms / Q000139:chemically induced*; D011247:Pregnancy; D014481:United States; D014486:United States Food and Drug Administration; D014594:Uterine Neoplasms / Q000139:chemically induced
D003271:Contraceptive Agents, Female; D017258:Medroxyprogesterone Acetate; D008525:Medroxyprogesterone